Related Experiment Video
Updated: Feb 18, 2026

13:46
An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons
Published on: July 11, 2020
6.3K
Neuroprotective potential of high-dose biotin
Mark F McCarty1, James J DiNicolantonio2
1Catalytic Longevity, 811 B Nahant Ct., San Diego, CA 92109, USA.
Medical Hypotheses
|November 19, 2017
Summary
High-dose biotin stabilizes multiple sclerosis (MS) progression by boosting cyclic guanosine monophosphate (cGMP) in the brain. This mechanism may also offer neuroprotection for Alzheimer's disease (AD) and stroke.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- High-dose biotin (100 mg TID) has shown a stabilizing effect on multiple sclerosis (MS) progression in clinical trials.
- The mechanism is often attributed to biotin's cofactor role, but direct stimulation of soluble guanylate cyclase (sGC) by pharmacological biotin concentrations is proposed.
- This stimulation leads to increased cyclic guanosine monophosphate (cGMP) levels in the brain.
Purpose of the Study:
- To explore the potential neuroprotective mechanisms of high-dose biotin beyond its cofactor role in MS.
- To investigate the role of biotin-induced cGMP production in neuronal survival, plasticity, and disease modulation.
- To assess the potential of high-dose biotin in managing neurodegenerative diseases like Alzheimer's disease (AD) and stroke.
Main Methods:
- Review of existing literature on biotin's effects, cGMP signaling pathways, and neuroprotection.
- Analysis of how cGMP influences neuronal survival, plasticity, and disease-specific mechanisms (e.g., amyloid beta in AD).
- Consideration of potential synergistic effects with phosphodiesterase-5 inhibitors.
Main Results:
- Pharmacological biotin concentrations may directly stimulate sGC, increasing brain cGMP levels.
- cGMP exerts neurotrophic-mimetic effects, promoting neuron survival and plasticity via PI3K-Akt and Ras-ERK pathways.
- In AD models, cGMP counteracts amyloid beta's inhibition of long-term potentiation and suppresses amyloid precursor protein and BACE1 expression.
- cGMP also promotes neurogenesis and may reduce stroke risk by affecting cerebral vasculature.
Conclusions:
- High-dose biotin's therapeutic effects in MS may involve direct sGC stimulation and subsequent cGMP elevation.
- Biotin-induced cGMP offers broad neuroprotective potential, including in Alzheimer's disease and stroke prevention.
- Concurrent use of brain-permeable phosphodiesterase-5 inhibitors could enhance biotin's neuroprotective effects.
Related Concept Videos
Vitamins
2.6K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.6K
Sulfur Assimilation
392
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
392
The Blood-brain Barrier
53.6K
Overview
53.6K
Bioactivation and Tissue Toxicity
25
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
25
Drug Toxicity: Risk factors
27
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
27

